Skip to content

Dispensing Evaluation of Investigational Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02625220
Enrollment
177
Registered
2015-12-09
Start date
2015-10-31
Completion date
2015-11-30
Last updated
2017-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia; Astigmatism

Brief summary

Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.

Interventions

DEVICEPrototype toric lens senofilcon A

Investigational prototype

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult males or females that are ≥18 years of age and ≤39 years of age. * The subject must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form. * The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. * The subject must be a habitual toric contact lens wearer. Habitual wearer is defined as someone who wears toric lenses for at least 6 hours a day, 5 days a week for the past 30 days. * Subject's vertex corrected spherical component of their distance refraction must be between -1.50 Diopters Sphere (DS) to -4.00 DS (inclusive) in each eye. * Subject's vertex corrected refractive cylinder must be between -0.75 and -1.50 Diopters Cylinder (DC) (inclusive) in each eye. * Subject's refractive cylinder axis must be within 180±15° and 90±15° in each eye. * If needed, the subject must have a wearable pair of spectacles with 20/30 or better vision Ocular Uterque (OU). If spectacles are not needed, the subject must have 20/40 or better vision OU without correction. * Subject's best corrected distance acuity must be 20/25-2 or better in each eye.

Exclusion criteria

* Females who are currently pregnant or lactating. * Any ocular or systemic allergies or diseases that may contraindicate contact lens wear. * Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, and/or Stevens-Johnson syndromes, by self-report. * Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV), by self-report. * Habitual wearer of extended wear contact lenses. * Any previous history of ocular and/or refractive surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.) * History of seizures. * Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by report. * History of binocular vision abnormality or strabismus, by self-report. * Habitual wearer of rigid gas permeable (RGP) lenses, orthokeratology lenses, or hybrid lenses (e.g. SynergEyes, SoftPerm) within the past 6 months. * Employee and family members of employee of investigational clinic (e.g., Investigator, Coordinator, Technician). * Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment. * Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, and conjunctival injection) on the FDA classification scale. * Any history of a contact lens-related corneal inflammatory event within the past year that may contraindicate contact lens wear. * Any active ocular infection. * Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. * Any fluctuations in vision due to clinically significant dry eye or other ocular conditions.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Eyes With Monocular Visual Acuity Better Than 20/407 day follow-upMonocular visual acuity was assessed using distance Snellen visual acuity. Visual Acuity data was dichotomized such that 'response=1' if a subjects has 20/40 or better and 'response=0' if subject has worse than 20/40. The proportion of eyes with 20/40 or better was reported.
The Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees15 Minutes Post InsertionAbsolute rotation was measured using a slit lamp. Absolute rotation measured at 15-minute post insertion was categorized into a binary outcome as 'response=1' if the absolute rotation is less than or equal to 10 degrees or 'response=0' otherwise. The proportion of eyes with absolute rotation less than or equal to 10 degrees was reported.
Proportion of Subjects Eyes With Lens Stability With Blink Within 5 Degrees15 Minutes Post InsertionLens stability with blink was measured using a slit lamp. The rotational stability of the lens during a series of normal (unforced) blinks was measured for both eyes. The data was dichotomized as 'response=1' if the lens stability was less than or equal to 5 degrees or 'response=0' otherwise. The proportion of eyes with rotational stability of 5 degrees or lower was reported.
Proportion of Subject Eyes With Acceptable Lens Fit15 Minute Post InsertionAcceptability of contact lens fit was assessed via slit lamp and was reported as a binary response as Acceptable or Unacceptable. The proportion of eyes with acceptable fit was reported.

Countries

United States

Participant flow

Pre-assignment details

A total of 177 subjects were enrolled into this study. Of the enrolled subjects, 7 did not meet the eligibility criteria and 170 subjects were dispensed a study lens. Of the dispensed subjects, 7 were discontinued and 163 completed the study.

Participants by arm

ArmCount
Prototype Toric Lens Senofilcon A
All subjects in this study were dispensed the prototype toric lens senofilcon A in this study.
170
Total170

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event2
Overall StudyLost to Follow-up2
Overall StudyProtocol Violation1
Overall StudyStudy discontinued at site2

Baseline characteristics

CharacteristicPrototype Toric Lens Senofilcon A
Age, Continuous28.8 Years
STANDARD_DEVIATION 5.71
Race/Ethnicity, Customized
American Indian or Native Alaskian
4 Participants
Race/Ethnicity, Customized
Asian
7 Participants
Race/Ethnicity, Customized
Black or African American
19 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
2 Participants
Race/Ethnicity, Customized
Other
7 Participants
Race/Ethnicity, Customized
White
131 Participants
Region of Enrollment
United States
170 participants
Sex: Female, Male
Female
112 Participants
Sex: Female, Male
Male
58 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 170
serious
Total, serious adverse events
0 / 170

Outcome results

Primary

Proportion of Eyes With Monocular Visual Acuity Better Than 20/40

Monocular visual acuity was assessed using distance Snellen visual acuity. Visual Acuity data was dichotomized such that 'response=1' if a subjects has 20/40 or better and 'response=0' if subject has worse than 20/40. The proportion of eyes with 20/40 or better was reported.

Time frame: 7 day follow-up

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation (per-protocol). One subject was excluded from the analysis population due to a major protocol deviation.

ArmMeasureValue (NUMBER)
Prototype Toric Lens Senofilcon AProportion of Eyes With Monocular Visual Acuity Better Than 20/401.0 proportion of Subject Eyes
Primary

Proportion of Subject Eyes With Acceptable Lens Fit

Acceptability of contact lens fit was assessed via slit lamp and was reported as a binary response as Acceptable or Unacceptable. The proportion of eyes with acceptable fit was reported.

Time frame: 15 Minute Post Insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation (per-protocol). One subject was excluded from the analysis population due to a major protocol deviation.

ArmMeasureValue (NUMBER)
Prototype Toric Lens Senofilcon AProportion of Subject Eyes With Acceptable Lens Fit1.0 proportion of Subject Eyes
Primary

Proportion of Subjects Eyes With Lens Stability With Blink Within 5 Degrees

Lens stability with blink was measured using a slit lamp. The rotational stability of the lens during a series of normal (unforced) blinks was measured for both eyes. The data was dichotomized as 'response=1' if the lens stability was less than or equal to 5 degrees or 'response=0' otherwise. The proportion of eyes with rotational stability of 5 degrees or lower was reported.

Time frame: 15 Minutes Post Insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation (per-protocol). One subject was excluded from the analysis population due to a major protocol deviation.

ArmMeasureValue (NUMBER)
Prototype Toric Lens Senofilcon AProportion of Subjects Eyes With Lens Stability With Blink Within 5 Degrees1.0 proportion of Subject Eyes
Primary

The Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees

Absolute rotation was measured using a slit lamp. Absolute rotation measured at 15-minute post insertion was categorized into a binary outcome as 'response=1' if the absolute rotation is less than or equal to 10 degrees or 'response=0' otherwise. The proportion of eyes with absolute rotation less than or equal to 10 degrees was reported.

Time frame: 15 Minutes Post Insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation (per-protocol). One subject was excluded from the analysis population due to a major protocol deviation.

ArmMeasureValue (NUMBER)
Prototype Toric Lens Senofilcon AThe Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees0.993 proportion of Subject Eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026